Boston Scientific CEO Mahoney Buys More Than 200k Shares for $10 Million. What Does This Mean for Investors in 2026?

Michael F. Mahoney, CEO of Boston Scientific, recently purchased over 200,000 shares of the company's stock for more than $10 million, significantly increasing his stake. This substantial insider buy is generally viewed as a bullish signal, especially given the company's recent challenges and upcoming product pipeline. The article suggests that while insider purchases are not a guarantee of future stock performance, such a significant investment by the CEO warrants a closer look from investors.